We deliver cutting-edge molecular products to laboratories and clinical researchers seeking better genomic answers. Our patented technology — Anchored Multiplex PCR (AMP™) — is at the core of our industry-leading products. We offer a suite of products and services that are accurate, personal and easy-to-use in local settings.
Blood cancer research panels leverage a powerful technology for error-corrected next-generation sequencing for high sensitivity oncogene profiling.
Blood cancer research panels detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS). This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, point mutations, copy number variations (CNVs) and other variant types from a single sample.
Our flexible technology and design expertise enable high performance customization of biomarker targets and bespoke applications.
Design your own panel with genes of interest for targeted next-generation sequencing (NGS) using RNA, DNA or ctDNA. We offer two options for custom panel creation: Assay Designer and Designer Pro.
Solid tumor research panels provide a robust targeted sequencing approach to detect critical biomarkers from both liquid and tissue biopsies.
Solid tumor research panels offer a sensitive targeted sequencing approach for biomarker detection from both liquid and tissue biopsies. This approach leverages DNA, RNA or ctDNA input types for sensitive characterization of all variant types from low-input clinical samples.